Flavonoids: An alternative pathway for the treatment of Alzheimer's disease

被引:12
作者
Das, Paramita [1 ]
Preethi, K. [1 ]
Kiruba, A. Angelin [1 ]
Nayak, Anjali [1 ]
机构
[1] Krupanidhi Coll Pharm, Dept Pharm, Bangalore 560035, Karnataka, India
来源
ANNALS OF PHYTOMEDICINE-AN INTERNATIONAL JOURNAL | 2021年 / 10卷 / 02期
关键词
Alzheimer's; Antioxidant; Dementia; Flavonoids; Tau-phosphorylation; OXIDATIVE STRESS; KAEMPFEROL; MORIN; NEUROINFLAMMATION; MECHANISMS; APIGENIN; FISETIN; GINKGO; RUTIN; TAU;
D O I
10.21276/ap.2021.10.2.33
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Alzheimer's is a non-curative disease that occurs in most of the geriatric patients worldwide. It is one of the top 10 diseases which lead to mortality. According to Indian statistics 2020, the average age for symptoms to occur in Alzheimer's is 66-68 years. Patients can survive up to 8 years after the symptoms of dementia. Women are predominant than men. As there is no permanent treatment for Alzheimer's, but medication and management strategies may temporarily improve. On the basis of clinical trials, it can be suggested that single herbs may offer complementary benefits to the approved drugs. Flavonoids are used prophylactically to treat Alzheimer's, as flavonoids are present in most of the fruits, vegetables, and other daily essential products like apple, berries, spinach, red cabbage, onion, dark chocolate, green tea, etc. Flavonoids are also used to treat early symptoms of Alzheimer's like learning and memory loss as flavonoids cross blood-brain barrier (BBB) and prevent tangles. Natural flavonoids mainly possess antioxidant and neuroprotective action which helps to restore damaged brain cells up to a certain extent. Myricetin, morin. rutin, quercetin, fisetin, ginkgo biloba extract, genistein, kaempferol, apigenin, anthocyanin, glycitein are some of the flavonoids used in prevention of Alzheimer's disease. In present study, we discuss different flavonoids to prevent and treat symptoms that are associated with Alzheimer's disease.
引用
收藏
页码:240 / 251
页数:12
相关论文
共 84 条
[1]   Rutin ameliorates oxidative stress and preserves hepatic and renal functions following exposure to cadmium and ethanol [J].
Abarikwu, Sunny O. ;
Njoku, Rex-Clovis ;
Lawrence, Chiamaka J. ;
Charles, Iniobong A. ;
Ikewuchi, Jude C. .
PHARMACEUTICAL BIOLOGY, 2017, 55 (01) :2161-2169
[2]   Anthocyanins Potentially Contribute to Defense against Alzheimer's Disease [J].
Afzal, Mohammad ;
Redha, Amina ;
AlHasan, Redha .
MOLECULES, 2019, 24 (23)
[3]   Flavonoids in the Treatment of Alzheimer's and Other Neurodegenerative Diseases [J].
Airoldi, Cristina ;
La Ferla, Barbara ;
D'Orazio, Giuseppe ;
Ciaramelli, Carlotta ;
Palmioli, Alessandro .
CURRENT MEDICINAL CHEMISTRY, 2018, 25 (27) :3228-3246
[4]  
Anand David Alexander Victor, 2016, Pharmacogn Rev, V10, P84, DOI 10.4103/0973-7847.194044
[5]  
Annoni F., 1986, MINERVA MED, V77
[6]   Ginkgo biloba L. (Ginkgoaceae) Leaf Extract Medications From Different Providers Exhibit Differential Functional Effects on Mouse Frontal Cortex Neuronal Networks [J].
Bader, Benjamin M. ;
Juegelt, Konstantin ;
Schultz, Luise ;
Schroeder, Olaf H. -U. .
FRONTIERS IN PHARMACOLOGY, 2018, 9
[7]   Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer's disease [J].
Balez, Rachelle ;
Steiner, Nicole ;
Engel, Martin ;
Munoz, Sonia Sanz ;
Lum, Jeremy Stephen ;
Wu, Yizhen ;
Wang, Dadong ;
Vallotton, Pascal ;
Sachdev, Perminder ;
O'Connor, Michael ;
Sidhu, Kuldip ;
Muench, Gerald ;
Ooi, Lezanne .
SCIENTIFIC REPORTS, 2016, 6
[8]   Metabolism of Rutin and Poncirin by Human Intestinal Microbiota and Cloning of Their Metabolizing α-L-Rhamnosidase from Bifidobacterium dentium [J].
Bang, Seo-Hyeon ;
Hyun, Yang-Jin ;
Shim, Juwon ;
Hong, Sung-Woon ;
Kim, Dong-Hyun .
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2015, 25 (01) :18-25
[9]   Metabolism, Oral Bioavailability and Pharmacokinetics of Chemopreventive Kaempferol in Rats [J].
Barve, Avantika ;
Chen, Chi ;
Hebbar, Vidya ;
Desiderio, Joseph ;
Saw, Constance Lay-Lay ;
Kong, Ah-Ng .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2009, 30 (07) :356-365
[10]  
Bethesda. NCBINational Center for Biotechnology Information, 2013, GLYCITEIN CID 531775